Fonte: Medical and Pediatric Oncology. Unidade: FMRP
Assuntos: ONCOLOGIA, PEDIATRIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SCRIDELI, C A et al. Polimerase chain reaction to monitor minimal residual disease in childhood b linfage acute leukemia: a simplified strategy. Medical and Pediatric Oncology, v. 25, n. 4 , p. 323, 1995Tradução . . Acesso em: 17 out. 2024.APA
Scrideli, C. A., Simoes, A. L., Defavery, R., Duarte, M. H. O., Bernardes, J. E., & Tone, L. G. (1995). Polimerase chain reaction to monitor minimal residual disease in childhood b linfage acute leukemia: a simplified strategy. Medical and Pediatric Oncology, 25( 4 ), 323.NLM
Scrideli CA, Simoes AL, Defavery R, Duarte MHO, Bernardes JE, Tone LG. Polimerase chain reaction to monitor minimal residual disease in childhood b linfage acute leukemia: a simplified strategy. Medical and Pediatric Oncology. 1995 ;25( 4 ): 323.[citado 2024 out. 17 ]Vancouver
Scrideli CA, Simoes AL, Defavery R, Duarte MHO, Bernardes JE, Tone LG. Polimerase chain reaction to monitor minimal residual disease in childhood b linfage acute leukemia: a simplified strategy. Medical and Pediatric Oncology. 1995 ;25( 4 ): 323.[citado 2024 out. 17 ]